Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shareholder Update

11 Mar 2022 14:00

RNS Number : 5415E
Non-Standard Finance PLC
11 March 2022
 

Non-Standard Finance plc

 

('NSF', the 'Company' or the 'Group')

 

11 March 2022

 

Update on outstanding regulatory matters

As previously announced, the Group has been working to resolve certain outstanding regulatory matters so that it might then proceed with a substantial capital raise ('Capital Raise') that, if successful, would be used to fund customer redress as well as strengthen the Group's balance sheet and transform its prospects. Following recent developments, the Board is issuing the following update on these matters.

Independent regulatory reviews into branch-based lending and home credit

Having first agreed their scope with the FCA, independent reviews into both branch-based lending and home credit were initiated in 2021 to consider the read-across from the multi-firm review into guarantor loans and to ensure that recent decisions at the Financial Ombudsman Service were taken into account in assessing whether or not any customers may have suffered harm. 

Whilst the conclusion of the review into branch-based lending (Everyday Loans) was that there is no requirement for any customer redress, in home credit the conclusion was that there may have been harm and, following extensive discussions with the FCA about how this should be defined and the implications for future lending, the Directors of SD Taylor Limited (trading as 'Loans at Home') reluctantly concluded that the Loans at Home business is no longer viable and so have applied to the FCA to grant permission for Loans at Home to be placed into administration and to appoint insolvency practitioners from Grant Thornton UK LLP as administrators. The Boards of Loans at Home and of NSF are clear that this is the only option available in order to preserve value for creditors. As the operations and activities of Loans at Home are separate from the rest of the Group, the Board of NSF confirms that, having now agreed certain waivers with the Group's lenders, the administration of Loans at Home will have minimal impact on the rest of the Group's business.

Proposed redress methodology in guarantor loans

Following the FCA's detailed review of the Group's proposed redress methodology for certain customers of its guarantor loans business, the Group is continuing to work with the FCA on finalising the operational mechanics of the scheme. The board is hopeful that this will soon be finalised in order to provide certainty for investors so that it can then proceed with the Capital Raise that, if successful, will be used to fund customer redress as well as strengthen the Group's balance sheet and transform its prospects.

Planned capital raise

The Group intends to complete a substantial capital raise as soon as practicable and considering the regulatory developments detailed above, the Group is in discussions with its lenders to support this effort. The Group's largest shareholder, Alchemy Special Opportunities Fund IV L.P.('Alchemy'), has confirmed its continued support for the proposed Capital Raise. Alchemy's support remains subject to: an outcome of the Group's engagement with its lenders that is acceptable to Alchemy; Alchemy's analysis of the outcome of the Group's discussions with the FCA regarding the regulatory position of the Group's divisions and the implications of that on (and Alchemy's assessment of) the Group's business plan and financial projections; and greater levels of certainty around redress and claims.

If successful, the Capital Raise will reduce high levels of gearing, fund the payment of redress to certain customers of the Group and underpin the future growth of its lending operations. Should the Capital Raise be unsuccessful or take longer than expected to execute, then it is expected that the Group would remain in a net liability position from a balance sheet perspective, would breach certain borrowing covenants and as a result would likely not be able to access further funding over the period of breach and would require additional waivers from its lenders. In such circumstance, there would be a material risk of the Group going into insolvency. However, the Directors continue to believe there is a reasonable prospect of resolving this position.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person responsible for making this announcement is the Director of IR and Communications.

 

Non-Standard Finance plc

Peter Reynolds, Director, IR and Communications

+44 (0) 20 3869 9026

 

Maitland/AMO

Neil Bennett

Finlay Donaldson

+44 (0) 20 7379 5151

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFVVVLILLIF
Date   Source Headline
11th Mar 20222:00 pmRNSShareholder Update
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20213:56 pmRNSDirector/PDMR Shareholding
17th Dec 20213:52 pmRNSResults of General Meeting
2nd Dec 20217:00 amRNSAppointment of financial adviser and broker
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:36 pmRNSPrice Monitoring Extension
27th Oct 20214:40 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
14th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20214:06 pmRNSDirector/PDMR Shareholding
28th Sep 20214:37 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSUnaudited Half Year Results to 30 June 2021
24th Sep 20212:48 pmRNSPublication of 2021 half year results
10th Sep 20214:35 pmRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSDirectorate Change
27th Aug 20214:35 pmRNSPrice Monitoring Extension
26th Aug 20214:36 pmRNSPrice Monitoring Extension
24th Aug 20217:00 amRNSHolding(s) in Company - Correction
23rd Aug 20211:31 pmRNSHolding(s) in Company
23rd Aug 20211:30 pmRNSHolding(s) in Company
18th Aug 20214:35 pmRNSPrice Monitoring Extension
16th Aug 20214:54 pmRNSResults of General Meeting
6th Aug 20214:41 pmRNSSecond Price Monitoring Extn
6th Aug 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20212:47 pmRNSDirector/PDMR Shareholding
30th Jun 20212:09 pmRNSResult of AGM
30th Jun 20218:54 amRNSAudited full year results to 31 December 2020
30th Jun 20217:02 amRNSAudited full year results to 31 December 2020
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:36 pmRNSPrice Monitoring Extension
15th Jun 20217:00 amRNSNotification of results and trading update
17th May 20214:41 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
14th Apr 20214:41 pmRNSSecond Price Monitoring Extn
14th Apr 20214:35 pmRNSPrice Monitoring Extension
26th Mar 20213:37 pmRNSPurchase of shares - Non-Executive Director fees
23rd Feb 20217:00 amRNSTrading Update
8th Jan 20214:41 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSDirector/PDMR Shareholding
5th Nov 202012:05 pmEQSHardman & Co Research: Non-Standard Finance Plc (NSF): 1H'20 results:
2nd Nov 20203:56 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSUnaudited Half Year Results to 30 June 2020
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 202010:06 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.